More from the American Society of Clinical Oncology meeting: GSK (GSK) presents positive results...


More from the American Society of Clinical Oncology meeting: GSK (GSK) presents positive results from late-stage trials of its trametinib and dabrafenib treatments for skin cancer, while Bayer's (BAYRY.PK) regorafenib delays progression of stomach cancer.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs